Abstract:Background: Type 1 diabetes (T1D) is an autoimmune disorder characterized by the destruction of insulin-producing pancreatic β cells. Understanding the immune mechanisms underlying T1D is crucial for developing effective diagnostic and therapeutic strategies. This study aimed to elucidate the immune mechanisms of T1D by integrating single-cell RNA sequencing (scRNA-seq), bulk RNA-seq, and experimental validation. Methods: scRNA-seq data (GSE200695) and bulk RNA-seq data (GSE9006) were obtained from the Gene Expression Omnibus (GEO) database. After data preprocessing, principal component analysis (PCA), and clustering, cell subtypes were annotated using ImmGenData as a reference. Receptor-ligand interactions were analyzed to identify key cell subtypes. Least absolute shrinkage and selection operator (LASSO) regression was performed to identify characteristic genes and construct a diagnostic model. Key genes were further validated using the training and validation sets. Functional enrichment and immune infiltration analyses were conducted for the key genes. In vitro experiments were performed to validate the findings using a high-glucose model in the monocytic cell line THP-1. siRNA-mediated knockdown of TRIB1 was performed to investigate its role in regulating monocyte activation and immune-related pathways under high-glucose conditions. Monocyte activation markers, inflammatory cytokines, apoptosis, and the expression of key genes and immune-related genes were assessed using immunofluorescence staining, ELISA, flow cytometry, qPCR, and Western blot. Results: Monocytes were identified as the key cell subtype with the most interactions with other cell subtypes. Eleven characteristic genes were selected to construct a diagnostic model, which demonstrated high validation efficiency (AUC > 0.8). Three key genes (ACTG1, REL, and TRIB1) showed consistent expression trends in the training and validation sets. Functional analyses revealed that these genes were involved in immune regulation and PI3K/AKT/mTOR signaling. In vitro experiments confirmed that high glucose induced monocyte activation, as evidenced by increased expression of activation markers (CD86) and pro-inflammatory cytokines (IL-8 and TNF-α). High glucose also increased monocyte apoptosis and altered the expression of key genes (ACTG1, REL, and TRIB1) and immune-related genes (CXCL16, TGFBR1, CTLA4, CD48, TMIGD2, and HLA-DPB1). Knockdown of TRIB1 attenuated high glucose-induced monocyte activation, as demonstrated by decreased expression of activation markers and pro-inflammatory cytokines. TRIB1 knockdown also modulated the expression of immune-related genes and PI3K/AKT/mTOR signaling under high-glucose conditions. Conclusions: This study integrates scRNA-seq, bulk RNA-seq, and experimental validation to unravel the immune mechanisms of T1D. Key genes (ACTG1, REL, and TRIB1) and monocytes were identified as crucial players in T1D pathogenesis. The constructed diagnostic model showed high validation efficiency. In vitro experiments confirmed the role of TRIB1 in regulating monocyte activation and immune-related pathways in a high-glucose model. These findings provide novel insights into the immune mechanisms of T1D and potential diagnostic and therapeutic targets.

Role of DNA-LL37 complexes in the activation of plasmacytoid dendritic cells and monocytes in subjects with type 1 diabetes

LL37/self-DNA complexes mediate monocyte reprogramming

KIR2DL5+CD8+ T cells associate with dietary lipid intake and are active in type 1 diabetes

Persistent STAT5 Phosphorylation and Epigenetic Dysregulation of GM-CSF and PGS2/COX2 Expression in Type 1 Diabetic Human Monocytes

Mitochondrial DNA Activates the NLRP3 Inflammasome and Predisposes to Type 1 Diabetes in Murine Model.

111-OR: Macrophage IPLA2ß-Derived Lipid (idl) Signaling Promote Type 1 Diabetes Development

Structural and biochemical analysis of highly similar HLA-B allotypes differentially associated with type 1 diabetes

PLAGL1 overexpression induces cytoplasmic DNA accumulation that triggers cGAS/STING activation

Lipid Mediators and Biomarkers Associated with Type 1 Diabetes Development

Immune mechanisms of type 1 diabetes revealed by single-cell transcriptomics, bulk transcriptomics, and experimental validation

Identification of Immune Gene Signature Associated with T Cells and Natural Killer Cells in Type 1 Diabetes

Dna Methylation Impairs Tlr9 Induced Foxp3 Expression by Attenuating Irf-7 Binding Activity in Fulminant Type 1 Diabetes

Lipopolysaccharide-Activated B Cells Down-Regulate Th1 Immunity and Prevent Autoimmune Diabetes in Nonobese Diabetic Mice1

CXCL12-CXCR4 Mediates CD57+ CD8+ T Cell Responses in the Progression of Type 1 Diabetes.

Expression of Interferon-Stimulated Genes in Insulitic Pancreatic Islets of Patients Recently Diagnosed With Type 1 Diabetes

Identification of monocyte-related transcriptomic signature of peripheral blood mononuclear cells in type 1 diabetes

Monocytes in type 1 diabetes families exhibit high cytolytic activity and subset abundances that correlate with clinical progression

Elevated Histone H3 Acetylation is Associated with Genes Involved in T Lymphocyte Activation and Glutamate Decarboxylase Antibody Production in Patients with Type 1 Diabetes

Expression of CD1 Molecules in Peripheral Monocytes and Lymphocytes in Type 1 Diabetes Patients Aged 15-25 Years

Relationship Between Th17 Cells and Type 1 Diabetes Mellitus

Evidence of Contribution of Ipla2β-Mediated Events During Islet Β-Cell Apoptosis Due to Proinflammatory Cytokines Suggests a Role for Ipla2β in T1D Development.